(-)-demecolcine increases expression ISO AKAP9 (Homo sapiens) 6480464 Demecolcine results in increased expression of AKAP9 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate decreases expression ISO AKAP9 (Homo sapiens) 6480464 epigallocatechin gallate results in decreased expression of AKAP9 protein CTD PMID:31195006 1,10-phenanthroline increases expression ISO AKAP9 (Homo sapiens) 6480464 1 and 10-phenanthroline results in increased expression of AKAP9 mRNA CTD PMID:19502547 1,2-dimethylhydrazine decreases expression ISO Akap9 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of AKAP9 mRNA CTD PMID:22206623 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine decreases expression EXP 6480464 chlorcyclizine results in decreased expression of AKAP9 mRNA CTD PMID:21058326 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of AKAP9 mRNA CTD PMID:20068009 and PMID:32145629 17beta-estradiol decreases expression ISO AKAP9 (Homo sapiens) 6480464 Estradiol results in decreased expression of AKAP9 mRNA CTD PMID:31614463 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Akap9 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Akap9 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Akap9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of AKAP9 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKAP9 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AKAP9 mRNA CTD PMID:34747641 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Akap9 (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of AKAP9 mRNA CTD PMID:17982090 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of AKAP9 mRNA CTD PMID:21346803 2-butoxyethanol decreases expression ISO Akap9 (Mus musculus) 6480464 n-butoxyethanol results in decreased expression of AKAP9 mRNA CTD PMID:19812364 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of AKAP9 protein CTD PMID:34915118 8-Br-cAMP decreases expression ISO AKAP9 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AKAP9 mRNA CTD PMID:22079614 acetazolamide increases expression ISO Akap9 (Mus musculus) 6480464 Acetazolamide results in increased expression of AKAP9 mRNA CTD PMID:19274763 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of AKAP9 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO Akap9 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of AKAP9 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO AKAP9 (Homo sapiens) 6480464 Tretinoin results in decreased expression of AKAP9 mRNA CTD PMID:15498508 all-trans-retinoic acid multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [Tretinoin co-treated with arsenic trioxide] results in decreased expression of AKAP9 protein CTD PMID:15894607 all-trans-retinoic acid increases expression ISO AKAP9 (Homo sapiens) 6480464 Tretinoin results in increased expression of AKAP9 mRNA and Tretinoin results in increased expression of AKAP9 protein CTD PMID:15894607 and PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AKAP9 mRNA CTD PMID:16483693 antirheumatic drug multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of AKAP9 mRNA CTD PMID:16817978 arsane decreases expression ISO AKAP9 (Homo sapiens) 6480464 Arsenic results in decreased expression of AKAP9 mRNA CTD PMID:16835338 arsenic atom decreases expression ISO AKAP9 (Homo sapiens) 6480464 Arsenic results in decreased expression of AKAP9 mRNA CTD PMID:16835338 arsenous acid affects expression ISO AKAP9 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of AKAP9 protein CTD PMID:15894607 arsenous acid multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of AKAP9 protein CTD PMID:15894607 arsenous acid increases expression ISO AKAP9 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of AKAP9 mRNA CTD PMID:20458559 benzo[a]pyrene decreases expression ISO Akap9 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of AKAP9 mRNA CTD PMID:20713471 benzo[a]pyrene diol epoxide I decreases expression ISO AKAP9 (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AKAP9 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO Akap9 (Mus musculus) 6480464 bisphenol A results in decreased expression of AKAP9 mRNA CTD PMID:33221593 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of AKAP9 mRNA CTD PMID:30816183 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AKAP9 mRNA and bisphenol A results in decreased expression of AKAP9 protein CTD PMID:24552547 and PMID:32145629 bisphenol F multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of AKAP9 gene CTD PMID:31601247 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of AKAP9 protein CTD PMID:28903499 butanal decreases expression ISO AKAP9 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of AKAP9 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO Akap9 (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of AKAP9 mRNA CTD PMID:24982889 caffeine decreases expression ISO AKAP9 (Homo sapiens) 6480464 Caffeine results in decreased expression of AKAP9 protein CTD PMID:31195006 carbon nanotube decreases expression ISO Akap9 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO AKAP9 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to AKAP9 gene] CTD PMID:28238834 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of AKAP9 mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO Akap9 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of AKAP9 mRNA CTD PMID:37019170 chromium(6+) affects expression ISO Akap9 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of AKAP9 mRNA CTD PMID:28472532 clorgyline increases expression ISO AKAP9 (Homo sapiens) 6480464 Clorgyline results in increased expression of AKAP9 mRNA CTD PMID:19691856 cobalt dichloride increases expression ISO AKAP9 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of AKAP9 mRNA CTD PMID:19376846 copper(II) sulfate decreases expression ISO AKAP9 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of AKAP9 mRNA CTD PMID:19549813 coumarin 460 increases expression ISO AKAP9 (Homo sapiens) 6480464 4-methyl-7-diethylaminocoumarin results in increased expression of AKAP9 mRNA CTD PMID:19502547 cyclosporin A affects expression ISO AKAP9 (Homo sapiens) 6480464 Cyclosporine affects the expression of AKAP9 mRNA CTD PMID:25562108 cyproconazole decreases expression ISO Akap9 (Mus musculus) 6480464 cyproconazole results in decreased expression of AKAP9 mRNA CTD PMID:22334560 diarsenic trioxide multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of AKAP9 protein CTD PMID:15894607 diarsenic trioxide increases expression ISO AKAP9 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of AKAP9 mRNA CTD PMID:20458559 diarsenic trioxide affects expression ISO AKAP9 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of AKAP9 protein CTD PMID:15894607 dicrotophos decreases expression ISO AKAP9 (Homo sapiens) 6480464 dicrotophos results in decreased expression of AKAP9 mRNA CTD PMID:28302478 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of AKAP9 mRNA CTD PMID:21658437 diuron decreases expression EXP 6480464 Diuron results in decreased expression of AKAP9 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 emetine multiple interactions ISO AKAP9 (Homo sapiens) 6480464 Emetine inhibits the reaction [sodium arsenite affects the localization of AKAP9 protein] CTD PMID:19073175 epoxiconazole decreases expression ISO Akap9 (Mus musculus) 6480464 epoxiconazole results in decreased expression of AKAP9 mRNA CTD PMID:22334560 ethanol increases expression ISO Akap9 (Mus musculus) 6480464 Ethanol results in increased expression of AKAP9 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO AKAP9 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of AKAP9 mRNA CTD PMID:23649840 fenthion decreases expression ISO Akap9 (Mus musculus) 6480464 Fenthion results in decreased expression of AKAP9 mRNA CTD PMID:34813904 finasteride increases expression EXP 6480464 Finasteride results in increased expression of AKAP9 mRNA CTD PMID:24136188 formaldehyde decreases expression ISO AKAP9 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of AKAP9 mRNA CTD PMID:20655997 formaldehyde increases expression ISO AKAP9 (Homo sapiens) 6480464 Formaldehyde results in increased expression of AKAP9 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of AKAP9 gene CTD PMID:31601247 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of AKAP9 mRNA CTD PMID:20080153 menadione affects expression ISO AKAP9 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of AKAP9 mRNA CTD PMID:20044591 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of AKAP9 mRNA CTD PMID:30467583 methotrexate multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of AKAP9 mRNA CTD PMID:16817978 methyl methanesulfonate increases expression ISO AKAP9 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of AKAP9 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO AKAP9 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of AKAP9 mRNA CTD PMID:28001369 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of AKAP9 gene CTD PMID:33148267 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AKAP9 mRNA CTD PMID:20360939 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of AKAP9 mRNA CTD PMID:19041683 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKAP9 mRNA CTD PMID:25729387 ozone multiple interactions ISO Akap9 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of AKAP9 mRNA CTD PMID:27106289 paracetamol affects expression ISO Akap9 (Mus musculus) 6480464 Acetaminophen affects the expression of AKAP9 mRNA CTD PMID:17562736 paracetamol decreases expression ISO AKAP9 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of AKAP9 mRNA CTD PMID:21420995 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23829299 PCB138 multiple interactions ISO Akap9 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 pentachlorophenol increases expression ISO Akap9 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of AKAP9 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression ISO AKAP9 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of AKAP9 mRNA CTD PMID:27153767 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of AKAP9 gene CTD PMID:33148267 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AKAP9 mRNA CTD PMID:20360939 phenobarbital decreases expression ISO Akap9 (Mus musculus) 6480464 Phenobarbital results in decreased expression of AKAP9 mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of AKAP9 mRNA CTD PMID:19710929 progesterone decreases expression ISO AKAP9 (Homo sapiens) 6480464 Progesterone results in decreased expression of AKAP9 mRNA CTD PMID:18070364 propiconazole decreases expression ISO Akap9 (Mus musculus) 6480464 propiconazole results in decreased expression of AKAP9 mRNA CTD PMID:21278054 and PMID:22334560 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of AKAP9 mRNA CTD PMID:19228061 resveratrol multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of AKAP9 mRNA CTD PMID:23557933 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of AKAP9 mRNA CTD PMID:19013527 sarin increases expression ISO AKAP9 (Homo sapiens) 6480464 Sarin results in increased expression of AKAP9 mRNA CTD PMID:19522546 sarin decreases expression ISO AKAP9 (Homo sapiens) 6480464 Sarin results in decreased expression of AKAP9 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite multiple interactions ISO AKAP9 (Homo sapiens) 6480464 Emetine inhibits the reaction [sodium arsenite affects the localization of AKAP9 protein] CTD PMID:19073175 sodium arsenite increases expression ISO Akap9 (Mus musculus) 6480464 sodium arsenite results in increased expression of AKAP9 mRNA CTD PMID:36209798 sodium arsenite decreases expression ISO AKAP9 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of AKAP9 mRNA CTD PMID:28595984 sodium arsenite affects methylation ISO AKAP9 (Homo sapiens) 6480464 sodium arsenite affects the methylation of AKAP9 gene CTD PMID:28589171 sodium arsenite affects localization ISO AKAP9 (Homo sapiens) 6480464 sodium arsenite affects the localization of AKAP9 protein CTD PMID:19073175 succimer multiple interactions ISO Akap9 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AKAP9 mRNA CTD PMID:21641980 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of AKAP9 mRNA CTD PMID:24136188 tamibarotene decreases expression ISO AKAP9 (Homo sapiens) 6480464 tamibarotene results in decreased expression of AKAP9 mRNA CTD PMID:15498508 tert-butyl hydroperoxide decreases expression ISO AKAP9 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of AKAP9 mRNA CTD PMID:15336504 tetrachloroethene increases expression ISO Akap9 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of AKAP9 mRNA CTD PMID:28973375 thimerosal increases expression ISO AKAP9 (Homo sapiens) 6480464 Thimerosal results in increased expression of AKAP9 mRNA CTD PMID:27188386 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of AKAP9 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKAP9 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO AKAP9 (Homo sapiens) 6480464 trichostatin A results in decreased expression of AKAP9 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AKAP9 mRNA CTD PMID:27188386 triptonide decreases expression ISO Akap9 (Mus musculus) 6480464 triptonide results in decreased expression of AKAP9 mRNA CTD PMID:33045310 valproic acid affects expression ISO AKAP9 (Homo sapiens) 6480464 Valproic Acid affects the expression of AKAP9 mRNA CTD PMID:25979313 valproic acid decreases methylation ISO AKAP9 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of AKAP9 gene CTD PMID:29154799 valproic acid decreases expression ISO AKAP9 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of AKAP9 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO AKAP9 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AKAP9 mRNA CTD PMID:27188386 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of AKAP9 mRNA CTD PMID:29427782